Showing results (201-210 of 5,263) with videos related to

Sort By:
Pageof 527
European Journal of Haematology|January 6, 2004
Flavones inhibit proliferation and increase mediator content in human leukemic mast cells (HMC-1)Michael Alexandrakis, Richard Letourneau, Durajisamy Kempuraj, et al.
European Journal of Haematology|January 6, 2004
First case of immune-mediated haemolytic anaemia associated to imatinib mesylateMarcia C Zago Novaretti, Guilherme H H Fonseca, Mônika Conchon, et al.
European Journal of Haematology|January 6, 2004
Lymphoma complicating common variable immunodeficiency with granulomatous disease: report of two casesVéronique Le Guern, Geneviève Le Roux, Antoine Martin, et al.
European Journal of Haematology|November 4, 2004
VH gene mutation status and cellular drug resistance in chronic lymphocytic leukaemiaAnna Aleskog, Gerard Tobin, Anna Laurell, et al.
European Journal of Haematology|November 4, 2004
Rituximab as treatment for minimal residual disease in hairy cell leukaemiaGiulia Cervetti, Sara Galimberti, Francesca Andreazzoli, et al.
European Journal of Haematology|November 4, 2004
Specific antibodies to mouse Sca-1- (Ly-6A/E) or Thy-1-positive haematopoietic progenitor cells induce formation of nitric oxide which inhibits subsequent colony formationArne Bøyum, Hege B Fjerdingstad, Vivi-Ann Tennfjord, et al.
European Journal of Haematology|November 4, 2004
Alemtuzumab: effective monotherapy for simultaneous B-cell chronic lymphocytic leukaemia and Sézary syndromeSimon D J Gibbs, Kirsten E Herbert, Christopher McCormack, et al.
European Journal of Haematology|February 1, 1992
A prospective randomized comparison of single-agent interferon (IFN)-alpha with the combination of IFN-alpha and low-dose IFN-gamma in chronic myelogenous leukaemiaO Kloke, U Wandl, B Opalka, et al.
European Journal of Haematology|February 1, 1992
Immune responses and serum levels of cytokines in adult T-cell leukemia patients and human T-cell leukemia virus type-I carriersT Nakasone, K Araki, M Masuda, et al.
European Journal of Haematology|February 1, 1992
Bolus therapy with mitoxantrone and vincristine in combination with high-dose prednisone (NOP-bolus) in resistant multiple myeloma. Nordic Myeloma Study Group (NMSG)F Wisløff, P Gimsing, M Hedenus, et al.
Pageof 527